12,091 VanEck Pharmaceutical ETF $PPH Shares Sold by Fluent Financial LLC

Fluent Financial LLC decreased its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 31.0% during the third quarter, HoldingsChannel reports. The firm owned 26,901 shares of the company’s stock after selling 12,091 shares during the quarter. VanEck Pharmaceutical ETF makes up about 1.1% of Fluent Financial LLC’s investment portfolio, making the stock its 23rd largest position. Fluent Financial LLC’s holdings in VanEck Pharmaceutical ETF were worth $2,945,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. TD Waterhouse Canada Inc. raised its holdings in shares of VanEck Pharmaceutical ETF by 130.0% in the second quarter. TD Waterhouse Canada Inc. now owns 230 shares of the company’s stock worth $25,000 after buying an additional 130 shares during the last quarter. IFP Advisors Inc grew its holdings in shares of VanEck Pharmaceutical ETF by 115.7% during the second quarter. IFP Advisors Inc now owns 537 shares of the company’s stock valued at $59,000 after buying an additional 288 shares during the last quarter. Continuum Advisory LLC acquired a new position in shares of VanEck Pharmaceutical ETF in the 2nd quarter valued at $68,000. Integrated Wealth Concepts LLC acquired a new position in shares of VanEck Pharmaceutical ETF in the 2nd quarter valued at $78,000. Finally, Cassaday & Co Wealth Management LLC acquired a new position in shares of VanEck Pharmaceutical ETF in the 1st quarter valued at $79,000.

VanEck Pharmaceutical ETF Stock Performance

PPH stock traded down $1.47 during midday trading on Tuesday, reaching $109.23. The stock had a trading volume of 346,675 shares, compared to its average volume of 311,203. The stock has a market cap of $1.03 billion, a PE ratio of 20.21 and a beta of 0.45. The firm has a fifty day simple moving average of $111.83 and a two-hundred day simple moving average of $107.52. VanEck Pharmaceutical ETF has a 52-week low of $90.60 and a 52-week high of $118.00.

VanEck Pharmaceutical ETF Cuts Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, October 6th. Shareholders of record on Thursday, October 1st were paid a dividend of $0.36 per share. This represents a $1.44 annualized dividend and a yield of 1.3%. The ex-dividend date was Thursday, October 1st. This is a drop from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.6248.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.